Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1992 1
1994 3
1995 1
1996 1
1997 3
1998 1
1999 6
2000 5
2001 8
2002 3
2003 8
2004 3
2005 5
2006 6
2007 8
2008 9
2009 7
2010 13
2011 6
2012 8
2013 5
2014 11
2015 12
2016 7
2017 16
2018 13
2019 8
2020 13
2021 10
2022 12
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Editorial.
Becquemont L, Picard N, Verstuyft C. Becquemont L, et al. Therapie. 2017 Apr;72(2):173-174. doi: 10.1016/j.therap.2017.01.004. Epub 2017 Jan 30. Therapie. 2017. PMID: 28238399 No abstract available.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Maladie de Gaucher de type 1 (CYP2D6-éliglustat).
Becquemont L. Becquemont L. Therapie. 2017 Apr;72(2):319-322. doi: 10.1016/j.therap.2016.09.013. Epub 2017 Jan 3. Therapie. 2017. PMID: 28189332 French. No abstract available.
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Pharmacogenetics of hypersensitivity drug reactions.
Negrini S, Becquemont L. Negrini S, et al. Among authors: becquemont l. Therapie. 2017 Apr;72(2):231-243. doi: 10.1016/j.therap.2016.12.009. Epub 2017 Jan 3. Therapie. 2017. PMID: 28162244 Review.
L'évaluation médico-économique des produits de santé dans le contexte de la loi de financement de la Sécurité sociale pour 2012.
Dervaux B, Baseilhac E, Fagon JY; les participants à la table ronde N°6 de Giens XXVIII :; Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A. Dervaux B, et al. Among authors: becquemont l. Therapie. 2013 Jul-Aug;68(4):253-7. doi: 10.2515/therapie/2013044. Therapie. 2013. PMID: 27392727 French. No abstract available.
Éditorial.
Becquemont L, Picard N, Verstuyft C. Becquemont L, et al. Therapie. 2017 Apr;72(2):171-172. doi: 10.1016/j.therap.2016.12.008. Epub 2017 Jan 3. Therapie. 2017. PMID: 28117096 French. No abstract available.
Habenular volume in depressed patients.
Etienne J, Boutigny A, Minh Ngoc Thien KTD, Ducreux D, Deflesselle E, Chappell K, Gressier F, Becquemont L, Corruble E, Colle R. Etienne J, et al. Among authors: becquemont l. Psychiatry Clin Neurosci. 2023 Mar;77(3):191-192. doi: 10.1111/pcn.13518. Epub 2022 Dec 24. Psychiatry Clin Neurosci. 2023. PMID: 36468830 Free article. No abstract available.
199 results